- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 14-11-2025: General Updates
14-11-2025 | 10:41 am
14-11-2025 | 10:41 am
US FDA closed the Warning Letter for Apitoria Pharma's Unit-I facility, classifying its inspection as Voluntary Action Indicated (VAI). This positive development should benefit the subsidiary's operations.
No comments yet. Be the first to comment!